Barcelona Bio-HF calculator version 3.0: recalibration and incorporation of sodium-glucose cotransporter 2 inhibitor treatment.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE
    • Publication Information:
      Publication: 2014- : Chichester : Wiley
      Original Publication: Amsterdam ; New York : Elsevier Science, c1999-
    • Subject Terms:
      Heart Failure*/drug therapy ; Heart Failure*/metabolism ; Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use; Humans ; Glucose ; Sodium
    • Comments:
      Comment in: Eur J Heart Fail. 2023 Mar;25(3):441. (PMID: 36693809)
      Comment in: Eur J Heart Fail. 2023 Mar;25(3):441-442. (PMID: 36789582)
    • References:
      Codina P, Lupón J, Borrellas A, Spitaleri G, Cediel G, Domingo M, et al. Head-to-head comparison of contemporary heart failure risk scores. Eur J Heart Fail. 2021;23:2035-44.
      Butler J, Packer M, Filippatos G, Ferreira JP, Zeller C, Schnee J, et al. Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction. Eur Heart J. 2022;43:416-26.
      Jhund PS, Kondo T, Butt JH, Docherty KF, Claggett BL, Desai AS, et al. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and deliver. Nat Med. 2022;28:1956-64.
      Lupón J, de Antonio M, Vila J, Peñafiel J, Galán A, Zamora E, et al. Development of a novel heart failure risk tool: the Barcelona Bio-Heart Failure risk calculator (BCN Bio-HF calculator). PLoS One. 2014;9:e85466.
      Lupón J, Simpson J, McMurray JJV, de Antonio M, Vila J, Subirana I, et al. Barcelona Bio-HF calculator version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization. Eur J Heart Fail. 2018;20:938-40.
    • Accession Number:
      0 (Sodium-Glucose Transporter 2 Inhibitors)
      IY9XDZ35W2 (Glucose)
      9NEZ333N27 (Sodium)
    • Publication Date:
      Date Created: 20221215 Date Completed: 20230131 Latest Revision: 20230406
    • Publication Date:
      20230407
    • Accession Number:
      10.1002/ejhf.2752
    • Accession Number:
      36519628